Loading organizations...
Scrub Capital is a venture capital firm dedicated to reshaping early-stage healthcare investing. It employs a unique model integrating insights from clinicians, founders, operators, and technology experts. This approach leverages deep industry knowledge to cultivate innovative healthcare solutions, offering comprehensive support alongside financial capital.
The firm was co-founded in 2024 by Dr. Rebecca Mitchell, Dr. Jonathan Slotkin, and Christina Farr. Their foundational insight was that impactful healthcare solutions arise from teams with a profound understanding of real-world clinical challenges. The founders bring significant clinical, operational, and digital health expertise, aiming to infuse medical practice directly into investment decisions.
Scrub Capital supports ambitious founders developing solutions to advance the future of health. By prioritizing investments rooted in clinical realities, the firm accelerates the development of impactful healthcare technologies and services. Its vision is to foster an ecosystem where clinical expertise directly informs and propels successful innovation within the healthcare landscape.
Key people at Scrub Capital.
Key people at Scrub Capital.
Scrub Capital has 4 tracked investments across 4 companies. The latest tracked deal is $14.5M Series A in Clarity Pediatrics in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 17, 2025 | Clarity Pediatrics | $14.5M Series A | Victor Echevarria | City Light Capital, GingerBread Capital, Homebrew, MassMutual, Maverick Ventures, Operator Collective, Rethink Impact |
| Dec 9, 2025 | Radial | $50.0M Series A | Reva Nohria | Diede VAN Lamoen, BoxGroup, Founder Collective, JSL Health, Solari Capital |
| Jun 25, 2025 | SuperDial | $15.0M Debt / Series A | SignalFire | BoxGroup, Slow Ventures |
| Jan 15, 2025 | Conceivable Life Sciences | $18.0M Series A | — | Aike HO, Atlantic Health Venture Studio, Black Opal Ventures, Cadence Healthcare Ventures, Future Positive Capital, Muse Capital, Stride.VC, Time BioVentures |